FDA Grants New Indication for Opdivo for Resected Esophageal or GEJ Cancer

… dyspnea, constipation, decreased appetite, back pain, arthralgia, upper respiratory tract infection, pyrexia, headache, abdominal pain and vomiting.
Source: back pain